Related Experiment Video

Updated: Jun 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia

Kristen M Kreisel1, J Kristie Johnson, O Colin Stine

  • 1Department of Epidemiology and Preventive Medicine, University of Maryland Baltimore, Baltimore, MD 21201, USA. kris03222001@yahoo.com

Emerging Infectious Diseases
|August 26, 2010
PubMed

Insights

Illicit drug users had a higher risk of USA300 methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. This strain appears to be spreading beyond drug users to the general patient population.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of healthcare-associated infections.
  • USA300 is a prevalent and virulent strain of MRSA in the United States.
  • Illicit drug use has been identified as a risk factor for various infections, including MRSA.

Purpose of the Study:

  • To investigate the association between illicit drug use and USA300 MRSA bacteremia.
  • To determine if this association has changed over time.
  • To understand the potential transmission dynamics of USA300 MRSA.

Main Methods:

  • A multicenter study was conducted across four Veterans Affairs medical centers.
  • Data were collected from 2004 to 2008.
  • Statistical analysis was used to assess the relative risk of USA300 MRSA bacteremia in illicit drug users compared to non-users.

Main Results:

  • Illicit drug users were significantly more likely to develop USA300 MRSA bacteremia compared to non-users (adjusted relative risk 3.0).
  • The association between illicit drug use and USA300 MRSA bacteremia showed a decreasing trend over the study period, though not statistically significant (p = 0.23).
  • An increasing proportion of USA300 MRSA bacteremia cases occurred in patients who did not use illicit drugs.

Conclusions:

  • Illicit drug use is a strong risk factor for USA300 MRSA bacteremia.
  • The findings suggest that the USA300 MRSA strain has disseminated from illicit drug users to the broader patient population.
  • Continued surveillance and infection control measures are crucial to curb the spread of virulent MRSA strains.

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...